Loctek(300729)
Search documents
乐歌股份(300729) - 2024 Q4 - 年度业绩预告
2025-01-13 10:04
Profit Decline - Net profit attributable to shareholders is expected to be between 300 million and 340 million yuan, a decrease of 52.66%-46.35% compared to the same period last year[3] - Non-recurring net profit is expected to be between 180 million and 210 million yuan, a decrease of 28.56%-16.65% compared to the same period last year[3] - The decline in net profit is mainly due to a significant decrease in non-recurring income from the sale of overseas warehouses[5] - Increased investment in new product R&D, marketing, and IT personnel has contributed to the decline in net profit[5] Overseas Operations - Overseas warehouse operating area has significantly increased, with new accounting lease standards and longer installation processes affecting capacity release[6] - High shipping costs have impacted the profitability of cross-border e-commerce business[6]
乐歌股份(300729) - 2024年第四季度可转换公司债券转股情况公告
2025-01-02 08:48
| 证券代码:300729 | 证券简称:乐歌股份 | 公告编号:2025-001 | | --- | --- | --- | | 债券代码:123072 | 债券简称:乐歌转债 | | 乐歌人体工学科技股份有限公司 2024 年第四季度可转换公司债券转股情况公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 特别提示 1、"乐歌转债"(债券代码:123072)转股期为 2021 年 4 月 27 日至 2026 年 10 月 20 日;最新有效的转股价格为 33.23 元/股。 3、截至 2024 年第四季度末,公司剩余可转债票面总金额为 141,839,800.00 元人民币。 根据《深圳证券交易所创业板股票上市规则》和《深圳证券交易所上市公司 自律监管指引第 15 号——可转换公司债券》的有关规定,乐歌人体工学科技股 份有限公司(以下简称"公司")现将 2024 年第四季度可转换公司债券(以下 简称"乐歌转债")转股及公司总股本变化情况公告如下: 一、可转换公司债券发行上市情况 1、发行上市基本情况 经中国证券监督管理委员会"证监许可[2020]195 ...
乐歌股份:关于签订募集资金四方监管协议的公告
2024-12-26 07:44
| 证券代码:300729 | 证券简称:乐歌股份 | 公告编号:2024-113 | | --- | --- | --- | | 债券代码:123072 | 债券简称:乐歌转债 | | 乐歌人体工学科技股份有限公司 关于签订募集资金四方监管协议的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整,没有虚假记载、 误导性陈述或重大遗漏。 一、募集资金基本情况 (一)2021 年向特定对象发行股票募集资金情况 根据乐歌人体工学科技股份有限公司(以下简称"公司")2021 年 1 月 12 日第四 届董事会第二十二次会议、2021 年 1 月 28 日 2021 年第一次临时股东大会决议、2021 年 4 月 21 日第四届董事会第二十六次会议、2021 年 8 月 9 日第四届董事会第三十一次会 议,并经中国证券监督管理委员会证监许可[2021]2380 号文同意注册,本公司向特定投 资者发行人民币普通股(A 股)38,716,814 股,每股发行价 18.08 元,募集资金总额为 人民币 699,999,997.12 元,扣除总发行费用人民币 9,758,223.37 元(不含增值税), 募集资金 ...
乐歌股份20241216
21世纪新健康研究院· 2024-12-17 04:06
Summary of Conference Call Company and Industry Overview - The discussion revolves around the company's performance in the cross-border e-commerce and overseas warehouse sectors, highlighting the gradual increase in service attributes and the strengthening of the company's supply chain capabilities [1][2]. Key Points and Arguments 1. **Overseas Warehouse Performance**: - Revenue growth in overseas warehouses continues to exceed expectations, with a significant increase in the number of warehouses opened [1]. - The utilization rate of overseas warehouses is expected to improve, with November showing record high revenues [4][10]. 2. **Operational Efficiency**: - The company anticipates a decrease in the efficiency rate for overseas warehouses from 6% last year to approximately 3-4% this year due to the ramp-up of new warehouses [2]. - Plans for next year include optimizing warehouse layouts to enhance capacity and efficiency [2]. 3. **Cross-Border E-Commerce**: - The overall growth in cross-border e-commerce is projected to be around 10-15%, despite intense competition and rising shipping costs impacting profitability [3][11]. - Shipping costs in Q3 were significantly higher than the previous year, affecting profits by tens of millions [3]. 4. **Domestic Sales Challenges**: - Domestic sales have seen a year-on-year decline of 20%, attributed to a challenging market environment [4][12]. - The company expects modest growth of 10-20% in domestic sales next year, primarily driven by e-commerce platforms [12]. 5. **Cost Management and Future Investments**: - The company is focusing on transitioning from smaller warehouses to larger ones, with plans to sell off smaller facilities for approximately $10-20 million [7]. - Future investments in self-built warehouses are expected to improve profit margins significantly, with construction costs estimated at under $100 per square foot [8]. 6. **Market Outlook**: - The company remains optimistic about the U.S. consumer market, expecting stable demand despite inflationary pressures [20]. - The impact of potential tariff increases on cross-border e-commerce is considered manageable, with shipping costs being a more significant concern [21]. 7. **Client Relationships and Supply Chain Dynamics**: - The company is not experiencing significant competition for orders, as many clients are still sourcing from China rather than shifting to other countries like Mexico or Vietnam due to cost considerations [15][17]. - The company continues to explore new client relationships while maintaining stable operations with existing clients [14][16]. Additional Important Insights - The company is actively negotiating new shipping contracts to manage costs better and is aware of the competitive landscape in the e-commerce sector [10][22]. - The overall sentiment regarding the future of cross-border e-commerce remains positive, with expectations of continued growth despite current challenges [19][20]. This summary encapsulates the key discussions and insights from the conference call, providing a comprehensive overview of the company's current performance and future outlook in the cross-border e-commerce and logistics sectors.
乐歌股份:关于公司第二期员工持股计划股票出售完毕的公告
2024-12-16 07:47
本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 乐歌人体工学科技股份有限公司(以下简称"公司")于 2022 年 5 月 31 日 召开了第五届董事会第二次会议和第五届监事会第二次会议,于 2022 年 6 月 21 日召开了 2022 年第一次临时股东大会,审议通过了《关于<乐歌人体工学科技股 份有限公司第二期员工持股计划(草案)>及其摘要的议案》《关于<乐歌人体工 学科技股份有限公司第二期员工持股计划管理办法>的议案》等相关议案,同意 公司实施第二期员工持股计划并授权董事会办理相关事宜。公司代"乐歌人体工 学科技股份有限公司第二期员工持股计划"与信托计划受托人陕西省国际信托股 份有限公司签署了《陕国投·乐歌股份第二期员工持股集合资金信托计划信托合 同》(以下简称"信托合同"),信托合同对信托计划的基本情况、期限和规模、 当事人的权利与义务等进行了详细的说明和约定,具体内容详见公司于中国证监 会指定的创业板信息披露网站巨潮资讯网(www.cninfo.com.cn)上披露的相关 公告。 根据中国证监会《关于上市公司实施员工持股计划试点的指导意见》及深圳 证券 ...
乐歌股份:关于完成工商变更登记并换发营业执照的公告
2024-12-16 07:47
| 证券代码:300729 | 证券简称:乐歌股份 公告编号:2024-112 | | --- | --- | | 债券代码:123072 | 债券简称:乐歌转债 | 乐歌人体工学科技股份有限公司 关于完成工商变更登记并换发营业执照的公告 类型:股份有限公司(港澳台投资、上市) 法定代表人:项乐宏 经营范围:一般项目:技术服务、技术开发、技术咨询、技术交流、技术转 让、技术推广;机械电气设备制造;家具零配件生产;家具制造;第一类医疗器 械生产;微特电机及组件制造;电子元器件与机电组件设备制造;家居用品制造; 体育用品及器材制造;电机及其控制系统研发;机械设备销售;技术进出口;进 出口代理;货物进出口;第一类医疗器械销售;第二类医疗器械销售;家具零配 件销售;微特电机及组件销售;电子元器件与机电组件设备销售;体育用品及器 材批发;体育用品及器材零售;办公用品销售;家居用品销售;软件销售;软件 开发;人工智能应用软件开发;人工智能理论与算法软件开发;人工智能基础软 件开发;信息咨询服务(不含许可类信息咨询服务);网络与信息安全软件开发(除 依法须经批准的项目外,凭营业执照依法自主开展经营活动)。 注册资本:叁亿肆 ...
乐歌股份:深度报告:智能家居与海外仓双轮驱动,品牌渠道协同发展
Yong Xing Zheng Quan· 2024-12-11 09:44
Investment Rating - The report assigns a "Buy" rating to the company, indicating a positive outlook based on its fundamentals and valuation expectations [2][148]. Core Insights - The company is a leading player in the smart home sector, focusing on linear drive technology for health-oriented office and smart home products. It operates both domestic and international brands, "Lege" and "Flexispot" respectively [2][16]. - The company has expanded its operations to include public overseas warehouse services, enhancing its logistics capabilities for large items in cross-border e-commerce, with 19 public overseas warehouses globally [2][16]. - In Q3 2024, the company achieved revenue of 39.75 billion yuan, a year-on-year increase of 48.03%, although net profit attributable to the parent company decreased by 8.64% due to rising costs [2][24]. - The linear drive market is projected to exceed 5 billion USD by 2024, driven by increasing demand for health office products and smart home applications [2][35][37]. - The company has a robust production capacity of over 2 million units annually, positioning it as a global leader in the linear drive sector [2][81]. Summary by Sections Company Overview - The company was established in 2002 and listed on the Shenzhen Stock Exchange in 2017. It specializes in health-oriented office and smart home products, with a focus on linear drive technology [2][16]. - The ownership structure is concentrated among the founding couple, ensuring stable control and a strong incentive alignment through stock options and employee stock ownership plans [2][18][22]. Financial Analysis - Revenue has grown significantly from 978 million yuan in 2019 to 3.902 billion yuan in 2023, with a CAGR of 59.85%. The growth is attributed to the rise in e-commerce penetration and health consumption trends [2][24]. - The company’s net profit increased from 63.4 million yuan in 2019 to 634 million yuan in 2023, with a CAGR of 112.18% [2][26]. - The company’s gross margin has fluctuated, with a recovery noted in 2023 due to improved operational efficiencies [2][33]. Linear Drive Sector - The linear drive industry is rapidly growing, with applications in health office products, smart homes, and medical devices. The market is expected to grow significantly, driven by increasing health awareness [2][35][39]. - The company has established a comprehensive value chain, from R&D to sales, enhancing its competitive edge in the linear drive market [2][62][75]. Overseas Warehouse Operations - The cross-border e-commerce logistics sector is expected to exceed 3.6 trillion yuan by 2025, with the company benefiting from its established overseas warehouse network [2][100]. - The company has over 10 years of experience in overseas warehouse operations, focusing on large item logistics, which enhances its market position [2][118]. - The company has strategically acquired land for warehouse development, ensuring a sustainable supply of logistics resources [2][131]. Profit Forecast and Valuation - Revenue projections for 2024-2026 are 55.48 billion yuan, 65.79 billion yuan, and 76.79 billion yuan, with expected growth rates of 42%, 19%, and 17% respectively [2][148]. - The company’s PE ratios for 2024-2026 are projected to be 14, 12, and 10, which are below the average of comparable companies, indicating a valuation advantage [2][148].
乐歌股份:关于乐歌转债回售结果的公告
2024-12-10 08:47
乐歌人体工学科技股份有限公司(以下简称"公司")根据《深圳证券交易 所创业板股票上市规则》、《深圳证券交易所上市公司自律监管指引第 15 号— —可转换公司债券》等法律法规的有关规定以及《乐歌人体工学科技股份有限公 司向不特定对象发行可转换公司债券募集说明书》的约定,于 2024 年 12 月 2 日、 2024 年 12 月 3 日、2024 年 12 月 4 日、2024 年 12 月 5 日、2024 年 12 月 6 日、 2024 年 12 月 9 日在指定的信息披露媒体《上海证券报》《证券时报》和巨潮资 讯网(www.cninfo.com.cn)上分别披露了《关于乐歌转债回售的公告》(公告编 号:2024-098)、《关于乐歌转债回售的第一次提示性公告》(公告编号:2024- 100)、《关于乐歌转债回售的第二次提示性公告》(公告编号:2024-104)、《关 于乐歌转债回售的第三次提示性公告》(告编号:2024-105)、《关于乐歌转债 回售的第四次提示性公告》(公告编号:2024-106)、《关于乐歌转债回售的第 五次提示性公告》(公告编号:2024-107)、《关于乐歌转债回售的第六次提示 ...
乐歌股份:关于乐歌转债恢复转股的提示性公告
2024-12-09 09:06
| 证券代码:300729 | 证券简称:乐歌股份 公告编号:2024-109 | | --- | --- | | 债券代码:123072 | 债券简称:乐歌转债 | 根据规定,自回售申报期结束的次一交易日(即 2024 年 12 月 10 日)起"乐 1、债券代码:123072 债券简称:乐歌转债 2、转股起止时间:2021 年 4 月 27 日至 2026 年 10 月 20 日 3、暂停转股时间:2024 年 12 月 3 日至 2024 年 12 月 9 日 4、恢复转股时间:2024 年 12 月 10 日 歌转债"恢复转股,敬请公司可转换公司债券持有人留意。 特此公告。 乐歌人体工学科技股份有限公司 关于"乐歌转债"恢复转股的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 特别提示: 乐歌人体工学科技股份有限公司(以下简称"公司")的股票自 2024 年 10 月 21 日至 2024 年 10 月 31 日连续九个交易日的收盘价低于当期"乐歌转债"转 股价格 34.78 元/股的 70%,即 24.35 元/股;2024 年 11 月 ...
乐歌股份:关于乐歌转债回售的第六次提示性公告
2024-12-09 09:06
本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 特别提示: | 证券代码:300729 | 证券简称:乐歌股份 公告编号:2024-108 | | --- | --- | | 债券代码:123072 | 债券简称:乐歌转债 | 乐歌人体工学科技股份有限公司 关于"乐歌转债"回售的第六次提示性公告 1、回售价格:100.412 元/张(含息税) 2、回售条件满足日:2024 年 11 月 29 日 3、回售申报期:2024 年 12 月 3 日至 2024 年 12 月 9 日 4、发行人资金到账日:2024 年 12 月 12 日 5、回售款划拨日:2024 年 12 月 13 日 6、投资者回售款到账日:2024 年 12 月 16 日 7、回售期内暂停转股 8、本次回售不具有强制性 9、风险提示:投资者选择回售等同于以 100.412 元/张(含当期利息)卖出持 有的"乐歌转债"。截至目前,"乐歌转债"的收盘价格高于本次回售价格,投 资者选择回售可能会带来损失,敬请投资者注意风险。 "乐歌转债"目前正处于最后两个计息年度,且公司股票自 2024 年 10 ...